Replies to post #210052 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

"The Company has been testing this approach in its Phase 3 trial of DCVax-L for newly diagnosed Glioblastoma, and is now working on various stages of preparations towards completion and unblinding of the trial...."

"The presentation concluded with a review of the practicality of DCVax-L for commercialization. Ms. Powers noted that all doses for a patient are manufactured in a single batch and stored frozen, that this enables repeated dosing of patients over a multi-year period, and that such doses are all "off the shelf" after the initial manufacturing." -- NWBIO, Jan 25, 2019

[Whitewater55]

Is it me or is this one of the weirdest press releases ever written? It’s almost like they just published someone’s written notes from the meeting without spending any time for editing. Total stream of consciousness. But then again, it’s something.

[marzan]

Thanks BSB!

[abeta]

BSB

You didn't have to and so -

VERY MUCH - THANK YOU FOR POSTING THAT ....

And notwithstanding some of its contents and its potential
veracity - I hope ALL those patients in the trial that you
posted - kick the shit out of their cancers.

regards

edit

just found out it was a press release - but thank you nonetheless

[notbrad]

Notice that the words "several months of.." is gone from the language.

The Company has been testing this approach in its Phase 3 trial of DCVax-L for newly diagnosed Glioblastoma, and is now working on various stages of preparations towards completion and unblinding of the trial.